...
首页> 外文期刊>Surgery >A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma.
【24h】

A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma.

机译:滤泡甲状腺肿瘤的病理学复习:改变阈值对甲状腺乳头状癌滤泡变型诊断的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editors:We would challenge the conclusions of the recent article published in Surgery by Widder et al, "A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma."1 In that study, the authors concluded that reclassification of follicular neoplasms increased malignant lesions in their patient group from 36% to 48%. Although no clinical ramifications were observed in the patients with the change of diagnosis, the ethical issues surrounding these 46 patients were important and presented a substantive quandary to the clinicians responsible for their care. We submit that the authors made an incorrect assumption about the accuracy of their review that led to an overstated conclusion.
机译:致编辑:我们将挑战Widder等人在《外科杂志》上发表的最新文章的结论:“滤泡性甲状腺肿瘤的病理学复习:改变诊断乳头状甲状腺癌的滤泡性变型的阈值的影响。 “ 1在该研究中,作者得出结论,将滤泡性肿瘤的重新分类将其患者组的恶性病变从36%增加到48%。尽管在诊断改变的患者中未观察到临床后果,但围绕这46名患者的道德问题很重要,对负责其护理的临床医生提出了实质性的难题。我们认为,作者对他们的评论的准确性做出了错误的假设,从而得出了夸大的结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号